This product is an antibody that recognizes IL-13. The antibody IMA-026 can be used for immunoassay techniques such as: WB.
Figure 1 Serum concentration of anti–IL-13 Ab in human dose-ranging studies.
Anti–IL-13 Abs were administered at the indicated doses and routes. IMA-026 in healthy volunteers. Serum concentrations of IMA-638 or IMA-026 were determined by ELISA.
Kasaian, M. T., Raible, D., Marquette, K., Cook, T. A., Zhou, S., Tan, X. Y., & Tchistiakova, L. (2011). IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. The Journal of Immunology, 187(1), 561-569.
Figure 2 Dose-dependent binding of IMA-638 to IL-13Rα2 in the presence of IL-13.
Kasaian, M. T., Raible, D., Marquette, K., Cook, T. A., Zhou, S., Tan, X. Y., & Tchistiakova, L. (2011). IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. The Journal of Immunology, 187(1), 561-569.
Figure 3 IL-13 and Ab internalization by confocal microscopy.
375 cells were fixed and permeabilized, and the intracellular cytokine was stained with Cy3 anti-FLAG. To study effects of anti–IL-13 Abs on IL-13 internalization, A375 cells were incubated for 24 h with FLAG-tagged IL-13 along with biotinylated Abs: control human IMA-026.
Kasaian, M. T., Raible, D., Marquette, K., Cook, T. A., Zhou, S., Tan, X. Y., & Tchistiakova, L. (2011). IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13Rα2. The Journal of Immunology, 187(1), 561-569.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-218 | Anti-Human IL13 Recombinant Antibody (Tralokinumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG4 - lambda |
TAB-068ZJ | Anti-Human IL-13 Recombinant Antibody (01471/G6) | WB, ELISA, Neut | Human antibody |
TAB-069ZJ | Human Anti-IL13 Recombinant Antibody (TAB-069ZJ) | ELISA, Neut, FC | Human IgG |
TAB-070ZJ | Human Anti-IL13 Recombinant Antibody (TAB-070ZJ) | ELISA, Neut, FC | Human IgG |
TAB-017ML | Anti-Human IL13 Recombinant Antibody (Dectrekumab) | ELISA, IHC, FC, IP, IF, Inhib | IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-219 | Anti-Human IL13 Recombinant Antibody (Lebrikizumab) | ELISA, Neut, IF, IP, FC, FuncS | IgG4 - kappa |
TAB-043ZJ | Anti-Human IL-13 Recombinant Antibody (Lc6Hc2) | ELISA | Humanized antibody |
TAB-044ZJ | Human Anti-IL13 Recombinant Antibody (TAB-044ZJ) | ELISA, Neut | Humanized IgG |
TAB-045ZJ | Human Anti-IL13 Recombinant Antibody (TAB-045ZJ) | ELISA, Block | Humanized IgG |
TAB-046ZJ | Human Anti-IL13 Recombinant Antibody (TAB-046ZJ) | ELISA, Block | Humanized IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-232 | Human Anti-IL13 Recombinant Antibody (clone M1295) | WB, IHC, FuncS | Human IgG |
HPAB-0226CQ | Human Anti-IL13 Recombinant Antibody (HPAB-0226CQ) | ELISA, Neut, FC, FuncS | Human IgG2 |
HPAB-0227CQ | Human Anti-IL13 Recombinant Antibody (HPAB-0227CQ) | ELISA, Neut, FC, FuncS | Human IgG2 |
HPAB-0228CQ | Mouse Anti-IL13 Recombinant Antibody (clone MJ2-7) | ELISA, FC, Neut, FuncS | Mouse IgG |
HPAB-0229CQ | Human Anti-IL13 Recombinant Antibody (clone huMJ2-7) | ELISA, FC, DB, Neut, FuncS | Humanized IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-232 | Human Anti-IL13 Recombinant Antibody (clone M1295); scFv Fragment | WB, IHC, FuncS | Human scFv |
HPAB-0355-WJ-S(P) | Human Anti-IL13 Recombinant Antibody (clone 13C5.5); scFv Fragment | ELISA | Humanized scFv |
HPAB-AP106-YC-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-AP106-YC-S(P)) | ELISA | Mouse scFv |
HPAB-AP107-YC-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-AP107-YC-S(P)) | ELISA | Mouse scFv |
HPAB-AP108-YC-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (HPAB-AP108-YC-S(P)) | ELISA | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-598 | Human Anti-IL13 Recombinant Antibody (clone C836); Fab Fragment | Neut | Chimeric (mouse/human) Fab |
PFBL-600 | Human Anti-IL13 Recombinant Antibody (clone H2L6); Fab Fragment | ELISA | Humanized Fab |
PFBL-601 | Human Anti-IL13 Recombinant Antibody (clone X836); Fab Fragment | WB, ELISA, FuncS | Chimeric (mouse/human) Fab |
HPAB-AP106-YC-F(E) | Mouse Anti-IL13 Recombinant Antibody; Fab Fragment (HPAB-AP106-YC-F(E)) | ELISA | Mouse Fab |
HPAB-AP107-YC-F(E) | Mouse Anti-IL13 Recombinant Antibody; Fab Fragment (HPAB-AP107-YC-F(E)) | ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-022ZJ | Anti-Human IL-13 Recombinant Antibody (C836) | ELISA | |
TAB-022ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (C836) | ELISA | |
TAB-023ZJ-S(P) | Mouse Anti-IL13 Recombinant Antibody; scFv Fragment (TAB-023ZJ-S(P)) | ELISA, Block | Mouse scFv |
TAB-022ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (C836) | ELISA | |
TAB-023ZJ-F(E) | Mouse Anti-IL13 Recombinant Antibody; Fab Fragment (TAB-023ZJ-F(E)) | ELISA, Block | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-094ZJ | Anti-Human IL-13 Recombinant Antibody (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-S(P) | Anti-Human IL-13 Recombinant Antibody scFv Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
TAB-094ZJ-F(E) | Anti-Human IL-13 Recombinant Antibody Fab Fragment (167) | ELISA | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-1171CQ | Mouse Anti-IL13 Recombinant Antibody (clone B-B13) | ELISA, ELISPOT, Neut | Mouse IgG1 |
NEUT-1172CQ | Mouse Anti-IL13 Recombinant Antibody (clone 10X28) | Neut, WB | Mouse IgG1 |
NEUT-1173CQ | Mouse Anti-IL13 Recombinant Antibody (clone 15H10) | Neut | Mouse IgG2b |
NEUT-1174CQ | Mouse Anti-IL13 Recombinant Antibody (clone 32116.11) | ELISA, Neut, WB | Mouse IgG1 |
NEUT-1175CQ | Rat Anti-IL13 Recombinant Antibody (clone 5A2) | Neut | Rat IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1790 | Rabbit Anti-IL13 Recombinant Antibody (clone DS1790AB) | WB, ICC, FC, IP | Rabbit IgG |
MOR-4610 | Rabbit Anti-IL13 Recombinant Antibody (clone TH123DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-H05 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Anrukinzumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | ADCC enhanced antibody |
AFC-TAB-017ML | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Dectrekumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
AFC-TAB-219 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Lebrikizumab), ADCC Enhanced | ELISA, Neut, IF, IP, FC, FuncS | ADCC enhanced antibody |
AFC-TAB-218 | Afuco™ Anti-IL13 ADCC Recombinant Antibody (Tralokinumab), ADCC Enhanced | ELISA, FC, IP, FuncS, IF, Neut | ADCC enhanced antibody |
There are currently no Customer reviews or questions for HPAB-0045LY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.